Adult bipolar disorder is continuous with pediatric bipolar disorder

Canadian Journal of Psychiatry

Volumn 52, Issue 7, 2007, Pages 418-425

  Chang, Kiki D ^a,b  

^a LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescents; Adults; Bipolar disorder; Children; Continuity; Genetics; Neurobiology

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LAMOTRIGINE; LITHIUM; METHIONINE; N ACETYLASPARTIC ACID; OLANZAPINE; OXCARBAZEPINE; QUETIAPINE; RISPERIDONE; SEROTONIN TRANSPORTER; TOPIRAMATE; VALINE; VALPROIC ACID;

AMYGDALOID NUCLEUS; ANXIETY; ATTENTION DEFICIT DISORDER; BIOLOGICAL TRAIT; BIPOLAR DISORDER; BORDERLINE STATE; CLINICAL TRIAL; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DNA POLYMORPHISM; DRUG EFFICACY; FAMILY HISTORY; GENE EXPRESSION; HUMAN; MANIA; NEUROBIOLOGY; OBSESSIVE COMPULSIVE DISORDER; PREFRONTAL CORTEX; RETROSPECTIVE STUDY; REVIEW; TREATMENT RESPONSE;

EID: 34547584141     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370705200703     Document Type: Review

References (99)

1. Carlson GA. Early onset bipolar disorder: clinical and research considerations. J Clin Child Adolesc Psychol. 2005;34(2):333-343.
2. Chang KD, Ketter TA. Special issues in the treatment of paediatric bipolar disorder. Expert Opin Pharmacother. 2001;2(4):613-622.
3. Biederman J, Mick E, Faraone SV, et al. Pediatric mania: a developmental subtype of bipolar disorder? Biol Psychiatry. 2000;48(6):458-466.
4. Craney JL, Geller B. A prepubertal and early adolescent bipolar disorder-I phenotype: review of phenomenology and longitudinal course. Bipolar Disord. 2003;5(4):243-256.
5. Findling RL, Gracious BL, McNamara NK, et al. Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar I disorder. Bipolar Disord. 2001;3(4):202-210.
6. Geller B, Zimerman B, Williams M, et al. Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2000;10(3):157-164.
7. Pavuluri MN, Birmaher B, Naylor MW. Pediatric bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 2005;44(9):846-871.
8. Wozniak J, Biederman J, Kwon A, et al. How cardinal are cardinal symptoms in pediatric bipolar disorder? An examination of clinical correlates. Biol Psychiatry. 2005;58(7):583-588.
9. Tillman R, Geller B. Definitions of rapid, ultrarapid, and ultradian cycling and of episode duration in pediatric and adult bipolar disorders: a proposal to distinguish episodes from cycles. J Child Adolesc Psychopharmacol. 2003;13(3):267-271.
10. Carter TD, Mundo E, Parikh SV, et al. Early age at onset as a risk factor for poor outcome of bipolar disorder. J Psychiatr Res. 2003;37(4):297-303.
11. Perlis RH, Miyahara S, Marangell LB, et al. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2004;55(9):875-881.
12. Geller B, Zimerman B, Williams M, et al. Phenomenology of prepubertal and early adolescent bipolar disorder: examples of elated mood, grandiose behaviors, decreased need for sleep, racing thoughts and hypersexuality. J Child Adolesc Psychopharmacol. 2002;12(1):3-9.
13. McClellan J. Commentary: treatment guidelines for child and adolescent bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(3):236-239.
14. Geller DA. Obsessive-compulsive and spectrum disorders in children and adolescents. Psychiatr Clin North Am. 2006;29(2):353-370.
15. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry. 1995;34(4):454-463.
16. Carlson GA, Jensen PS, Findling RL, et al. Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference. J Child Adolesc Psychopharmacol. 2003;13(1):13-27.
17. Craney J, Geller B. Clinical implications of antidepressant and stimulant use on switching from depression to mania in children. J Child Adolesc Psychopharmacol. 2003;13(2):201-204.
18. Lish JD, Dime-Meenan S, Whybrow PC, et al. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord. 1994;31(4):281-294.
19. Leverich GS, Altshuler LL, Frye MA, et al. Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. J Clin Psychiatry. 2003;64(5):506-515.
20. Leverich GS, McElroy SL, Suppes T, et al. Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol Psychiatry. 2002;51(4):288-297.
21. Leibenluft E, Charney DS, Towbin KE, et al. Defining clinical phenotypes of juvenile mania. Am J Psychiatry. 2003;160(3):430-437.
22. Marchand WR, Wirth L, Simon C. Delayed diagnosis of pediatric bipolar disorder in a community mental health setting. J Psychiatr Pract. 2006;12(2):128-133.
23. Brotman MA, Schmajuk M, Rich BA, et al. Prevalence, clinical correlates, and logitudinal course of severe mood dysregulation in children. Biol Psychiatry. 2006;60(9): 991-997.
24. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorder during adolescence and young adulthood in a community sample. Bipolar Disord. 2000;2(3 Pt 2):281-293.
25. Birmaher B, Axelson D, Strober M, et al. Clinical course of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry. 2006;63(2):175-183.
26. Axelson D. Bipolar NOS: results from the COBY Study. Paper presented at 4th Annual Pediatric Bipolar Disorder Conference; 2006; Chicago (IL).
27. Geller B, Tillman R, Craney JL, et al. Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Arch Gen Psychiatry. 2004;61(5):459-467.
28. Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet. 2003;123(1):48-58.
29. Althoff RR, Faraone SV, Rettew DC, et al. Family, twin, adoption, and molecular genetic studies of juvenile bipolar disorder. Bipolar Disord. 2005;7(6):598-609.
30. Strober M, Morrell W, Burroughs J, et al. A family study of bipolar I disorder in adolescence. Early onset of symptoms linked to increased familial loading and lithium resistance. J Affect Disord. 1988;15(3):255-268.
31. Neuman RJ, Geller B, Rice JP, et al. Increased prevalence and earlier onset of mood disorders among relatives of prepubertal versus adult probands. J Am Acad Child Adolesc Psychiatry. 1997;36(4):466-473.
32. Chang KD, Steiner H. Offspring studies in child and early adolescent bipolar disorder. In: Geller B, DelBello M, editors. Bipolar disorder in childhood and early adolescence. New York (NY): Guilford Press; 2003. p 107-129.
33. DelBello MP, Geller B. Review of studies of child and adolescent offspring of bipolar parents. Bipolar Disord. 2001;3(6):325-334.
34. Chang K, Steiner H, Dienes K, et al. Bipolar offspring: a window into bipolar disorder evolution. Biol Psychiatry. 2003;53(11):945-951.
35. Faraone SV, Biederman J, Mennin D, et al. Attention-deficit hyperactivity disorder with bipolar disorder: a familial subtype? J Am Acad Child Adolesc Psychiatry. 1997;36(10):1378-1387; discussion 1387-1390.
36. Geller B, Cooper TB, Sun K, et al. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry. 1998;37(2):171-178.
37. Tohen M, Kryzhanovskaya L, Carlso G, et al. Olanzapine in the treatment of acute mania in adolescents with bipolar I disorder: a 3-week randomized double-blind placebo-controlled study. Poster presented at 44th Annual Meeting of the American College of Neuropsychopharmacology; 2005; Waikoloa (HI).
38. Baldessarini RJ, Tondo L. Does lithium treatment still work? Evidence of stable responses over three decades. Arch Gen Psychiatry. 2000;57(2):187-190.
39. Tohen M, Jacobs TG, Grundy SL, et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry. 2000;57(9):841-849.
40. Delbello MP, Findling RL, Kushner S, et al. A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(6):539-547.
41. Kushner SF, Khan A, Lane R, et al. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials. Bipolar Disord. 2006;8(1):15-27.
42. Wagner KD, Kowatch RA, Emslie GJ, et al. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry. 2006;163(7):1179-1186.
43. Goodnick PJ. Anticonvulsants in the treatment of bipolar mania. Expert Opin Pharmacother. 2006;7(4):401-410.
44. Wagner KD, Weller EB, Carlson GA, et al. An open-label trial of divalproex in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2002;41(10):1224-1230.
45. Biederman J, Mick E, Wozniak J, et al. An open-label trial of risperidone in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2005;15(2):311-317.
46. DelBello MP, Kowatch RA, Adler CM, et al. A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry. 2006;45(3):305-313.
47. Chang K, Saxena K, Howe M. An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry. 2006;45(3):298-304.
48. Strakowski SM, Delbello MP, Adler CM. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatry. 2005;10(1):105-116.
49. Rauch SL, Shin LM, Wright CI. Neuroimaging studies of amygdala function in anxiety disorders. Ann N Y Acad Sci. 2003;985:389-410.
50. Thomas KM, Drevets WC, Dahl RE, et al. Amygdala response to fearful faces in anxious and depressed children. Arch Gen Psychiatry. 2001;58(11):1057-1063.
51. Donegan NH, Sanislow CA, Blumberg HP, et al. Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation. Biol Psychiatry. 2003;54(11):1284-1293.
52. Blumberg HP, Kaufman J, Martin A, et al. Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder. Arch Gen Psychiatry. 2003;60(12):1201-1208.
53. DelBello MP, Zimmerman ME, Mills NP, et al. Magnetic resonance imaging analysis of amygdala and other subcortical brain regions in adolescents with bipolar disorder. Bipolar Disord. 2004;6(1):43-52.
54. Frazier JA, Breeze JL, Makris N, et al. Cortical gray matter differences identified by structural magnetic resonance imaging in pediatric bipolar disorder. Bipolar Disord. 2005;7(6):555-569.
55. Chen BK, Sassi R, Axelson D, et al. Cross-sectional study of abnormal amygdala development in adolescents and young adults with bipolar disorder. Biol Psychiatry. 2004;56(6):399-405.
56. Dickstein DP, Milham MP, Nugent AC, et al. Frontotemporal alterations in pediatric bipolar disorder: results of a voxel-based morphometry study. Arch Gen Psychiatry. 2005;62(7):734-741.
57. Chang K, Karchemskiy A, Barnea-Goraly N, et al. Reduced amygdalar gray matter volume in familial pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(6):565-573.
58. Wilke M, Kowatch RA, DelBello MP, et al. Voxel-based morphometry in adolescents with bipolar disorder: first results. Psychiatry Res. 2004;131(1):57-69.
59. Pearlson GD, Barta PE, Powers RE, et al. Ziskind-Somerfeld Research Award 1996. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder. Biol Psychiatry. 1997;41(1):1-14.
60. Strakowski SM, DelBello MP, Sax KW, et al. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch Gen Psychiatry. 1999;56(3):254-260.
61. Altshuler LL, Bartzokis G, Grieder T, et al. Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity. Arch Gen Psychiatry. 1998;55(7):663-664.
62. Rajkowska G, Halaris A, Selemon LD. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry. 2001;49(9):741-752.
63. Drevets WC, Price JL, Simpson JR Jr, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 1997;386(6627):824-827.
64. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 1998;95(22):13290-13295.
65. Lopez-Larson MP, DelBello MP, Zimmerman ME, et al. Regional prefrontal gray and white matter abnormalities in bipolar disorder. Biol Psychiatry. 2002;52(2):93-100.
66. Chang K, Barnea-Goraly N, Karchemskiy A, et al. Cortical magnetic resonance imaging findings in familial pediatric bipolar disorder. Biol Psychiatry. 2005;58(3):197-203.
67. Lim KO, Rosenbloom MJ, Faustman WO, et al. Cortical gray matter deficit in patients with bipolar disorder. Schizophr Res. 1999;40(3):219-227.
68. Winsberg ME, Sachs N, Tate DL, et al. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry. 2000;47(6):475-481.
69. Sassi RB, Stanley JA, Axelson D, et al. Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients. Am J Psychiatry. 2005;162(11):2109-2115.
70. Chang K, Adleman N, Dienes K, et al. Decreased N-acetylaspartate in children with familial bipolar disorder. Biol Psychiatry. 2003;53(11):1059-1065.
71. Hashimoto K, Shimizu E, Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev. 2004;45(2):104-114.
72. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry. 2000;48(8):766-777.
73. Manji HK, Moore GJ, Chen G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry. 2000;48(8):740-754.
74. Yurgelun-Todd DA, Gruber SA, Kanayama G, et al. fMRI during affect discrimination in bipolar affective disorder. Bipolar Disord. 2000;2(3 Part 2):237-248.
75. Strakowski SM, Adler CM, Holland SK, et al. A preliminary fMRI study of sustained attention in euthymic, unmedicated bipolar disorder. Neuropsychopharmacology. 2004;29(9):1734-1740.
76. Blumberg HP, Leung HC, Skudlarski P, et al. A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry. 2003;60(6):601-609.
77. Chang K, Adleman NE, Dienes K, et al. Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: a functional magnetic resonance imaging investigation. Arch Gen Psychiatry. 2004;61(8):781-792.
78. Blumberg HP, Martin A, Kaufman J, et al. Frontostriatal abnormalities in adolescents with bipolar disorder: preliminary observations from functional MRI. Am J Psychiatry. 2003;160(7):1345-1347.
79. Faraone SV, Glatt SJ, Su J, et al. Three potential susceptibility loci shown by a genome-wide scan for regions influencing the age at onset of mania. Am J Psychiatry. 2004;161(4):625-630.
80. Neves-Pereira M, Mundo E, Muglia P, et al. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet. 2002;71(3):651-655.
81. Sklar P, Gabriel SB, McInnis MG, et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry. 2002;7(6):579-593.
82. Hong CJ, Huo SJ, Yen FC, et al. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology. 2003;48(4):186-189.
83. Nakata K, Ujike H, Sakai A, et al. Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett. 2003;337(1):17-20.
84. Kunugi H, Iijima Y, Tatsumi M, et al. No association between the Va166Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study. Biol Psychiatry. 2004;56(5):376-378.
85. Geller B, Badner JA, Tillman R, et al. Linkage disequilibrium of the brain-derived neurotrophic factor Va166Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry. 2004;161(9):1698-1700.
86. Skibinska M, Hauser J, Czerski PM, et al. Association analysis of brain-derived neurotrophic factor (BDNF) gene Va166Met polymorphism in schizophrenia and bipolar affective disorder. World J Biol Psychiatry. 2004;5(4):215-220.
87. Bellivier F, Golmard JL, Henry C, et al. Admixture analysis of age at onset in bipolar I affective disorder. Arch Gen Psychiatry. 2001;58(5):510-512.
88. Faraone SV, Lasky-Su J, Glatt SJ, et al. Early onset bipolar disorder: possible linkage to chromosome 9q34. Bipolar Disord. 2006;8(2):144-151.
89. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617-627.
90. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8-19.
91. Post RM, Leverich GS, Altshuler LL, et al. An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). Bipolar Disord. 2003;5(5):310-319.
92. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord. 2003;73(1-2):123-131.
93. Danielyan A, Pathak S, Kowatch RA, et al. Clinical characteristics of bipolar disorder in very young children. J Affect Disord. 2007;97(1-3):51-59. Epub 5 Jul 2006.
94. Biederman J, Mick E, Hammerness P, et al. Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children. Biol Psychiatry. 2005;58(7):589-594.
95. Kumra S, Jacobsen LK, Lenane M, et al. "Multidimensionally impaired disorder": is it a variant of very early-onset schizophrenia? J Am Acad Child Adolesc Psychiatry. 1998;37(1):91-99.
96. Stayer C, Sporn A, Gogtay N, et al. Multidimensionally impaired: the good news. J Child Adolesc Psychopharmacol. 2005;15(3):510-519.
97. Baldessarini RJ. A plea for integrity of the bipolar disorder concept. Bipolar Disord. 2000;2(1):3-7.
98. Soares JC, Gershon S. The diagnostic boundaries of bipolar disorder. Bipolar Disord. 2000;2(1):1-2.
99. Geller B, Tillman R. Prepubertal and early adolescent bipolar I disorder: review of diagnostic validation by Robins and Guze criteria. J Clin Psychiatry. 2005;66(Suppl 7):21-28.